Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

PEG/lecithin–liquid-crystalline Composite Hydrogels for Quasi-Zero-order Combined Release of Hydrophilic and Lipophilic Drugs

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Effect of Peg2000 on Drug Delivery Characterization from Solid Lipid Nanoparticles

Thermosensitive hydrogel based on poly(ether-ester anhydride) nanoparticle as drug delivery system: preparation, characterization and biocompatibility.

Controlled Release of Lysozyme-Loaded Microspheres in Hydrogel Implants

Hydrogel-assisted Delivery of Lipophilic Molecules into Aqueous Medium for Transdermal Medication Based on Environment-Specific, Regioselective Adsorption of Graphene Oxides

Sustained Release of PEG-g-chitosan Complexed DNA from Poly(lactide-Co-glycolide).

Mussel-inspired controllable drug release hydrogel for transdermal drug delivery: Hydrogen bond and ion-dipole interactions

Highly Efficient Hydrogel Encapsulation of Hydrophobic Drugs via an Organic Solvent-Free Process Based on Oiling-Out Crystallization and a Mechanism Study

Versatile Injectable Supramolecular Hydrogels Containing Drug Loaded Micelles for Delivery of Various Drugs

Synthesis, characterizations, and release mechanisms of carboxymethyl chitosan-graphene oxide-gelatin composite hydrogel for controlled delivery of drug

Designing hydrogel particles for controlled or targeted release of lipophilic bioactive agents in the gastrointestinal tract

In Vitro Evaluation of Lysozyme-loaded Microspheres in Thermosensitive Methylcellulose-based Hydrogel

Dual Ph-Responsive Hydrogel Actuator for Lipophilic Drug Delivery

Low Swelling Hyperbranched Poly(amine-Ester) Hydrogels for Ph-Modulated Differential Release of Anticancer Drugs

Injectable Block Copolymer Hydrogels for Sustained Release of a PEGylated Drug

Crosslinked Biodegradable Hybrid Hydrogels Based on Poly(ethylene glycol) and Gelatin for Drug Controlled Release

Thermo-responsive triblock copolymer micelles containing PEG6000 for either water-soluble or water-insoluble drug sustained release and treatment

Log P Determines Licorice Flavonoids Release Behaviors and Classification from CARBOMER Cross-Linked Hydrogel

Modification of solid form of drug in oil-in-water emulsion: Effect of self-assembly of the emulsifier glycyrrhizic acid

Blends of Hydrophobic and Swelling Agents in the Swelling Layer in the Preparation of Delayed-Release Pellets of a Hydrophilic Drug with Low MW: Physicochemical Characterizations and In-Vivo Evaluations